Rhodiola (Expanded) for Energy And Fatigue

Research suggests that Rhodiola rosea has a reasonably consistent body of evidence supporting its use for reducing fatigue and improving mental performance under stress, drawn from multiple review articles, a randomized controlled trial, and a meta-analysis that generally point in the same direction. Studies indicate that key bioactive compounds in the plant, including salidroside and rosavins, may influence stress-related biological pathways, neurotransmitter activity, and cortisol regulation, which researchers propose could underlie its reported effects on fatigue and mood. The available clinical evidence, including a 2015 randomized trial finding reduced self-reported stress and anxiety in mildly anxious adults and a 2021 meta-analysis supporting adaptogen use for chronic fatigue, tends to be supportive, though the evidence base has notable limitations including small sample sizes, short study durations, reliance on self-reported outcomes, and in at least one trial the absence of a placebo control, which makes it difficult to rule out expectation effects. Overall, Rhodiola appears to be a well-studied botanical in the adaptogen category with promising but not yet definitive evidence for energy and fatigue-related outcomes, and researchers generally call for larger, more rigorous trials to strengthen the conclusions.